Cocrystal Pharma director Phillip Frost reports $9,816 common share purchase
Reuters2026/08/06 21:26- Cocrystal Pharma director Phillip Frost reported an indirect purchase of 10,000 common shares at USD 0.98.
- Frost’s indirect stake held via Frost Gamma Investments Trust rose to 1,993,551 shares.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
GBP/JPY Price Forecast: Sellers eye 214.00 after SMA break
Bank of Canada keeps rates unchanged for the seventh consecutive time: Tariff wars increase inflation risk, 63% of analysts bet on a shift to rate hikes in the first half of 2027
On September 2, the Bank of Canada held its overnight rate at 2.25% for the seventh consecutive time. However, as the US-Canada tariff war has escalated and inflation risks have intensified, the market has shifted to betting on a rate hike. Governor Macklem warned that trade frictions will threaten the sustainability of the recovery. 63% of analysts expect the Bank of Canada to raise rates in the first half of 2027, while market pricing has shifted from expectations of easing to preparing for tightening in a stagflation scenario.
Crypto prices
More
